本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

40.61
+1.363.46%
盤前41.190.5800+1.43%04:49 EDT
成交量:81.14萬
成交額:3,276.62萬
市值:23.60億
市盈率:3.65
高:41.10
開:39.35
低:39.35
收:39.25
52周最高:62.58
52周最低:23.42
股本:5,810.15萬
流通股本:5,134.85萬
量比:1.38
換手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):11.13
每股收益(LYR):11.86
淨資產收益率:64.05%
總資產收益率:-25.71%
市淨率:1.72
市盈率(LYR):3.42

資料載入中...

2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

重要事件披露

Form 8-K - Current report
2025/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/31

重要事件披露

Form 8-K - Current report
2025/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/08

重要事件披露

Form 8-K - Current report
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/18

重要事件披露

Form 8-K - Current report
2025/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans